Read More

CRISPR Therapeutics Announces Leadership Transition; Co-Founder, Rodger Novak, M.D., To Step Down As President And Chairman; CEO Samarth Kulkarni, Ph.D., To Succeed Dr. Novak As Chairman Effective September 15, 2023

-CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September 15, 2023- -Samarth Kulkarni, Ph.D., to succeed Dr. Novak as Chairman and will continue serving as CEO of